SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Quarter 2016 Financial Results
[Sinovac Reports Unaudited First Quarter 2016 Financial Results BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights (compared to the first quarter of 2015) • Quarterly sales from continuing operations were $11.0 million, an increase] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v441538_6k.htm FORM 6-K]